The authors showed that GAS5 competed with PTEN for miR-21 binding, indicating a strong evidence that GAS5/miR-21/PTEN interactions are significant in cis-platin sensitivity in non-small cell lung cancer cells [58]. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.